Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 6Carcinoma, Hepatocellular 4Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Advanced Solid Tumors 2Advanced Lung Cancer 2Urinary Bladder Neoplasms 1Treatment-naive Advanced Non-small Cell Lung Cancer 1Sarcoma 1Recurrence 1Mouth Neoplasms 1Melanoma 1Lymphoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Rectal Cancer 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1High-Risk Resectable NSCLC 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Brain Neoplasms 1Anus Neoplasms 1Anal Canal Carcinoma 1Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy 1

Interventions

Fluorouracil 12Radiotherapy 8Cisplatin 8pembrolizumab 4Papillomavirus Vaccines 4Mitomycin 4Irinotecan 4Cyclophosphamide 4Cetuximab 4Light Coagulation 3Interleukin-12 Subunit p35 3Capecitabine 3fludarabine phosphate 2fludarabine 2atezolizumab 2aldesleukin 2Watchful Waiting 2Vaccines 2Trastuzumab 2Surveys and Questionnaires 2Radiation 2Quality of Life 2Paclitaxel 2Oxaliplatin 2Erlotinib Hydrochloride 2Early Intervention, Educational 2Carboplatin 2Biopsy 2toripalimab 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anus Neoplasms × toripalimab × Clear all
NCT05060471 2024-12-03

PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Sun Yat-sen University

Phase 2 Completed
25 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡